Maternal lipopolysaccharide exposure promotes immunological functional changes in adult offspring CD4+ T cells

American Journal of Reproductive Immunology

Volumn 73, Issue 6, 2015, Pages 522-535

  Luan, Rong ^a   Cheng, Hao ^a   Li, Lin ^c,d   Zhao, Qiang ^a   Liu, Hui ^a   Wu, Zhenzhou ^a   Zhao, Liqing ^a   Yang, Jinghua ^c   Hao, Jianlei ^b   Yin, Zhinan ^a,b  

^a NANKAI UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

CD4+ T cells study; Lipopolysaccharide; Maternal immune activation; Mouse model; Offspring immune response

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 17; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; IL17A PROTEIN, MOUSE;

ADULT; AMNION FLUID; ANIMAL CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL COMPOSITION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA MICROARRAY; ENVIRONMENTAL EXPOSURE; FEMALE; IMMUNE RESPONSE; INNATE IMMUNITY; LIQUID CHROMATOGRAPHY; LIVER; LYMPHOCYTE PROLIFERATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; SPLEEN; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; ADVERSE EFFECTS; ANIMAL; AUTISM; CHEMICALLY INDUCED; IMMUNOLOGY; MATERNAL EXPOSURE; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE;

ANIMALS; AUTISTIC DISORDER; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-17; LIPOPOLYSACCHARIDES; MATERNAL EXPOSURE; MICE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84929291622     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12364     Document Type: Article

References (61)

1. Gluckman PD, Hanson MA, Pinal C: The developmental origins of adult disease. Matern Child Nutr 2005; 1:130-141.
2. Sobrian SK, Vaughn VT, Ashe WK, Markovic B, Djuric V, Jankovic BD: Gestational exposure to loud noise alters the development and postnatal responsiveness of humoral and cellular components of the immune system in offspring. Environ Res 1997; 73:227-241.
3. Veru F, Laplante DP, Luheshi G, King S: Prenatal maternal stress exposure and immune function in the offspring. Stress 2014; 17:133-148.
4. Jackson P, Hougaard KS, Vogel U, Wu D, Casavant L, Williams A, Wade M, Yauk CL, Wallin H, Halappanavar S: Exposure of pregnant mice to carbon black by intratracheal instillation: toxicogenomic effects in dams and offspring. Mutat Res 2012; 745:73-83.
5. Cardenas I, Means RE, Aldo P, Koga K, Lang SM, Booth CJ, Manzur A, Oyarzun E, Romero R, Mor G: Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol 2010; 185:1248-1257.
6. Mor G: Cardenas: the immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63:425-433.
7. Ph P: Maternal effects on schizophrenia risk. Science 2007; 318:576-577.
8. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuese I, Yee BK, Feldon J: The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006; 26:4752-4762.
9. Nuzum JW, Pilot I, Stangl FH, Bonar BE: 1918 pandemic influenza and pneumonia in a large civil hospital. IMJ Ill Med J 1976; 150:612-616.
10. Atladóttir HO, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET: Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010; 40:1423-1430.
11. Schwartzer JJ, Careaga M, Onore CE, Rushakoff JA, Berman RF, Ashwood P: Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl Psychiatry 2013; 3:e240.
12. Makinodan M, Tatsumi K, Manabe T, Yamauchi T, Makinodan E, Matsuyoshi H, Shimoda S, Noriyama Y, Kishimoto T, Wanaka A: Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 2008; 86:2190-2200.
13. Baharnoori M, Bhardwaj SK, Srivastava LK: Effect of maternal lipopolysaccharide administration on the development of dopaminergic receptors and transporter in the rat offspring. PLoS ONE 2013; 8:e54439.
14. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH: Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007; 27:10695-10702.
15. Hsiao EY, Patterson PH: Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011; 25:604-615.
16. Onore C, Careaga M, Ashwood P: The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012; 26:383-392.
17. Patterson PH: Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009; 204:313-321.
18. Surriga O, Ortega A, Jadeja V, Bellafronte A, Lasala N, Zhou H: Altered hepatic inflammatory response in the offspring following prenatal LPS exposure. Immunol Lett 2009; 123:88-95.
19. Hsiao EY, McBride SW, Chow J, Mazmanian SK, Patterson PH: Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci USA 2012; 109:12776-12781.
20. Kirsten TB, Lippi LL, Bevilacqua E, Bernardi MM: LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1Beta levels in adult rat offspring: relevance to autism. PLoS ONE 2013; 8:e82244.
21. Onore CE, Schwartzer JJ, Careaga M, Berman RF, Ashwood P: Maternal immune activation leads to activated inflammatory macrophages in offspring. Brain Behav Immun 2014; 38:220-226.
22. Smale ST: Selective transcription in response to an inflammatory stimulus. Cell 2010; 140:833-844.
23. Jin B, Sun T, Yu XH, Yang YX, Yeo AE: The effects of TLR activation on T-cell development and differentiation. Clin Dev Immunol 2012; 2012:836485.
24. Bluestone JA, Mackay CR, O'Shea JJ, Stockinger B: The functional plasticity of T cell subsets. Nat Rev Immunol 2009; 9:811-816.
25. Zhou L, Chong MMW, Littman DR: Plasticity of CD4(+) T cell lineage differentiation. Immunity 2009; 30:646-655.
26. Murphy KM, Stockinger B: Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol 2010; 11:674-680.
27. Zhu JF, Paul WE: Heterogeneity and plasticity of T helper cells. Cell Res 2010; 20:4-12.
28. Nakayamada S, Takahashi H, Kanno Y, O'Shea J: Helper T cell diversity and plasticity. Curr Opin Immunol 2012; 24:297-302.
29. Williams CL, Teeling JL, Perry VH, Fleming TP: Mouse maternal systemic inflammation at the zygote stage causes blunted cytokine responsiveness in lipopolysaccharide-challenged adult offspring. BMC Biol 2011; 9:49.
30. Yin Z, Zhang D-H, Welte T, Bahtiyar G, Jung S, Liu L, Fu X-Y, Ray A, Craft J: Dominance of IL-12 over IL-4 in GD T cell differentiation leads to default production of IFN-g: failure to down-regulate IL-12 receptor b2-chain expression. J Immunol 2000; 164:3056-3064.
31. Quah BJ, Warren HS, Parish CR: Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007; 2:2049-2056.
32. Mi H, Muruganujan A, Casagrande JT, Thomas PD: Large-scale gene function analysis with the PANTHER classification system. Nat Protoc 2013; 8:1551-1566.
33. Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008; 3:1101-1108.
34. Wis'niewski JR, Zielinska DF, Mann M: Comparison of ultrafiltration units for proteomic and N-glycoproteomic analysis by filter-aided sample preparation method. Anal Biochem 2011; 410:307-309.
35. Li L, Shi L, Yang X, Ren L, Yang J, Lin Y: Role of invariant natural killer T cells in lipopolysaccharide-induced pregnancy loss. Cell Immunol 2013; 286:1-10.
36. Li L-P, Fang Y-C, Dong G-F, Lin Y, Saito S: Depletion of invariant NKT cells reduces inflammation-induced preterm delivery in mice. J Immunol 2012; 188:4681-4689.
37. Boyson J, Nagarkatti N, Nizam L, Exley M, Strominger J: Gestation stage-dependent mechanisms of invariant natural killer T cell-mediated pregnancy loss. Proc Natl Acad Sci USA 2006; 103:4580-4585.
38. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J: Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-411.
39. Aluvihare VR, Kallikourdis M, Betz AG: Regulatoty T cell mediate maternal torlerance to the fetus. Nat Immunol 2004; 5:266-271.
40. Teles A, Zenclussen AC, Schumacher A: Regulatory T cells are baby's best friends. Am J Reprod Immunol 2013; 69:331-339.
41. Walters SN, Webster KE, Daley S, Grey ST: A role for intrathymic B cells in the generation of natural regulatory T cells. J Immunol 2014; 193:170-176.
42. Lu L, Lan Q, Li ZY, Zhou XH, Gu J, Li Q, Wang JL, Chen MG, Liu Y, Shen Y, Brand DD, Ryffel B, Horwitz DA, Quismorio FP, Liu ZM, Li B, Olsen NJ, Zheng SG: Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA 2014; 111:E3432-E3440.
43. Mayer C, Ghorbani P, Kuhl A, Stuve P, Hegemann M, Berod L, Gershwin ME, Sparwasser T: Few Foxp3(+) regulatory T cells are sufficient to protect adult mice from lethal autoimmunity. Eur J Immunol 2014; 44:2990-3002.
44. Miyara M, Ito Y, Sakaguchi S: T-REG-cell therapies for autoimmune rheumatic diseases. Nat Rev Rheumatol 2014; 10:543-551.
45. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
46. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk H-D, Gaestel M: MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1999; 1:94-97.
47. González-Terán B, Cortés JR, Manieri E, Matesanz N, Verdugo Á, Rodríguez ME, González-Rodríguez Á, Valverde Á, Martín P, Davis RJ, Sabio G: Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis. J Clin Invest 2013; 123:164-178.
48. Baur FM, Brenner B, Goetze-Speer B, Neu S, Speer CP: Natural porcine surfactant (Curosur) down-regulates mRNA of tumor necrosis factor alfa (TNF-alfa) and TNF-alfa receptor type 2 receptor in lipopolysaccharide-stimulated monocytes. Pediatr Res 1998; 44:32-36.
49. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizuttani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T: IRF-7 is the master regulator of type-1 interferon dependent immue responses. Nature 2005; 434:772-777.
50. Siegfried A, Berchtold S, Manncke B, Deuschle E, Reber J, Ott T, Weber M, Kalinke U, Hofer MJ, Hatesuer B, Schughart K, Gailus-Durner V, Fuchs H, Hrabe de Angelis M, Weber F, Hornef MW, Autenrieth IB, Bohn E: IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF- a secretion and LPS-induced endotoxin shock. J Immunol 2013; 191:3913-3921.
51. Mandal M, Marzouk AC, Donnelly R, Ponzio NM: Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav Immun 2011; 25:863-871.
52. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR: The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126:1121-1133.
53. Saks VA, Ventura-Clapier R, Aliev MK: Metabolic control and metabolic capacity: two aspects of creatine kinase functioning in the cells. Biochim Biophys Acta 1996; 1274:81-88.
54. Koopman WJ, Nijtmans LG, Dieteren CE, Roestenberg P, Valsecchi F, Smeitink JA, Willems PH: Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species gerneration. Antioxid Redox Signal 2010; 12:1431-1470.
55. Pearce EL, Pearce EJ: Metabolic pathways in immune cell activation and quiescence. Immunity 2013; 38:633-643.
56. Dave VP: Role of CD3ε-mediated signaling in T-cell development and function. Crit Rev Immunol 2011; 31:73-84.
57. Hart MJ, Sharma S, elMasry N, Qiu R-G, McCabe P, Polakis P, Bollag G: Identification of a novel guanine nucleotide exchange factor for the Rho GTPase. J Biol Chem 1996; 271:25452-25458.
58. Burkhardt JK, Carrizosa E, Shaffer MH: The actin cytoskeleton in T cell activation. Annu Rev Immunol 2008; 26:233-259.
59. Talapatra S, Wagner J, Thompson C: Elongation factor-1 alpha is a selective regulator of growth factor withdrawal and ER stress-induced apoptosis. Cell Death Differ 2002; 9:856-861.
60. Blanch A, Robinson F, Watson IR, Cheng LS, Irwin MS: Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity. PLoS ONE 2013; 8:e66436.
61. Zager A, Peron JP, Mennecier G, Rodrigues SC, Aloia TP, Palermo-Neto J: Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring. Brain Behav Immun 2015; 43C:159-171.